The Islamic Emirate of Afghanistan (IEA) has announced that a major pharmaceutical manufacturing company will kick off its operation in Kandahar.
According to Zabiullah Mujahid, the IEA’s spokesman, the company, Snow Pharma, has been funded by 71 shareholders at a cost of $50 million and will produce a large percentage of medicines needed in the country.
Mujahid said that in one eight-hour shift, the factory will produce 5.6 million tablets, two million capsules and 60,000 bottles of syrup.
Snow Pharma shareholders are committed to spending another $50 million dollars in order to supply the country with pharmaceuticals in future.
Officials have welcomed the move and said this factory will provide hundreds of direct and indirect jobs to locals. In a visit to the factory in April, IEA officials also said the medicine produced at the factory would meet international standards.